STOK
Price:
$11.61
Market Cap:
$614.95M
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. Its lead clinical candidate is STK-001, which is in phase I/IIa clinical trial to treat Dravet syndrome, a severe and progressive genetic epilepsy; and STK-002, which is in preclinical stage for the treatment of autosomal dominant optic atrophy. It had entered into a license and collaboration agreement with Acadia Pharmaceuticals Inc. for the discovery...[Read more]
Industry
Biotechnology
IPO Date
2019-06-19
Stock Exchange
NASDAQ
Ticker
STOK
According to Stoke Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 467.23M. This represents a change of 14.38% compared to the average of 408.49M of the last 4 quarters.
The mean historical Enterprise Value of Stoke Therapeutics, Inc. over the last ten years is 560.71M. The current 467.23M Enterprise Value has changed 8.23% with respect to the historical average. Over the past ten years (40 quarters), STOK's Enterprise Value was at its highest in in the December 2020 quarter at 1.77B. The Enterprise Value was at its lowest in in the June 2019 quarter at -95915890.60.
Average
560.71M
Median
328.12M
Minimum
42.03M
Maximum
1.79B
Discovering the peaks and valleys of Stoke Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 523.68%
Maximum Annual Enterprise Value = 1.79B
Minimum Annual Increase = -83.04%
Minimum Annual Enterprise Value = 42.03M
Year | Enterprise Value | Change |
---|---|---|
2023 | 42.03M | -83.04% |
2022 | 247.83M | -66.42% |
2021 | 737.99M | -58.70% |
2020 | 1.79B | 523.68% |
2019 | 286.48M | -42.22% |
2018 | 495.80M | 51.10% |
The current Enterprise Value of Stoke Therapeutics, Inc. (STOK) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
342.62M
5-year avg
620.21M
10-year avg
560.71M
Stoke Therapeutics, Inc.’s Enterprise Value is greater than Adaptimmune Therapeutics plc (58.35M), greater than Homology Medicines, Inc. (-103303255.00), greater than Black Diamond Therapeutics, Inc. (123.50M), less than Harpoon Therapeutics, Inc. (861.85M), less than Relay Therapeutics, Inc. (623.90M), less than Pliant Therapeutics, Inc. (792.38M), less than Arvinas, Inc. (1.15B), greater than Passage Bio, Inc. (33.56M), greater than Atreca, Inc. (-8620212.00), greater than TCR2 Therapeutics Inc. (79.12M),
Company | Enterprise Value | Market cap |
---|---|---|
58.35M | $150.46M | |
-103303255.00 | $3.02M | |
123.50M | $123.92M | |
861.85M | $865.08M | |
623.90M | $726.44M | |
792.38M | $811.79M | |
1.15B | $1.24B | |
33.56M | $40.03M | |
-8620212.00 | $3.57M | |
79.12M | $58.11M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Stoke Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Stoke Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Stoke Therapeutics, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Stoke Therapeutics, Inc. (STOK)?
What is the 3-year average Enterprise Value for Stoke Therapeutics, Inc. (STOK)?
What is the 5-year average Enterprise Value for Stoke Therapeutics, Inc. (STOK)?
How does the current Enterprise Value for Stoke Therapeutics, Inc. (STOK) compare to its historical average?